SS Innovations International (SSII) Share-based Compensation (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.40% |
| Dec 31, 2025 | -3.42% |
| Sep 30, 2025 | 28.51% |
| Jun 30, 2025 | -31.48% |
| Mar 31, 2025 | 1.72% |
| Dec 31, 2024 | -4.59% |
| Sep 30, 2024 | 0.31% |
| Jun 30, 2024 | -65.62% |
| Mar 31, 2024 | -26.65% |
| Dec 31, 2023 | 39,535.55% |
| Sep 30, 2023 | 200.00% |
| Jun 30, 2023 | 100.51% |
| Mar 31, 2023 | -3,393.29% |
| Dec 31, 2022 | -106.31% |
| Sep 30, 2022 | 989.75% |
| Jun 30, 2022 | 135.57% |
| Mar 31, 2022 | -68.57% |
| Dec 31, 2021 | 238.52% |
| Sep 30, 2021 | -90.55% |
| Jun 30, 2021 | 60.96% |
| Mar 31, 2021 | 257.41% |
| Dec 31, 2020 | -151.99% |
| Sep 30, 2020 | 100.34% |
| Jun 30, 2020 | -40.49% |
| Mar 31, 2020 | 527.62% |
| Dec 31, 2019 | -337.61% |
| Sep 30, 2019 | -63.59% |
| Jun 30, 2019 | -63.32% |
| Mar 31, 2019 | 207.11% |
| Dec 31, 2018 | -364.19% |
| Sep 30, 2018 | 561.06% |
| Jun 30, 2018 | -81.32% |
| Mar 31, 2018 | -82.71% |
| Dec 31, 2017 | 1,732.65% |
| Sep 30, 2017 | -38.44% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -43.39% |
| Dec 31, 2016 | 186.94% |
| Sep 30, 2016 | -38.44% |